Westfield Capital Management Co. LP Increases Position in UnitedHealth Group Incorporated $UNH

Westfield Capital Management Co. LP grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 241,010 shares of the healthcare conglomerate’s stock after purchasing an additional 10,977 shares during the period. Westfield Capital Management Co. LP’s holdings in UnitedHealth Group were worth $83,221,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group during the second quarter worth approximately $25,000. Hurley Capital LLC raised its position in UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 40 shares during the period. Sagard Holdings Management Inc. purchased a new stake in UnitedHealth Group during the second quarter valued at about $29,000. Cloud Capital Management LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth about $32,000. Finally, Grey Fox Wealth Advisors LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $33,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $284.11 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock has a market cap of $257.35 billion, a PE ratio of 21.54, a price-to-earnings-growth ratio of 1.26 and a beta of 0.41. The company’s fifty day moving average price is $313.51 and its 200-day moving average price is $325.44. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same quarter in the previous year, the firm posted $6.81 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Monday, March 9th. UnitedHealth Group’s dividend payout ratio is currently 67.02%.

Analysts Set New Price Targets

Several brokerages have weighed in on UNH. Mizuho lowered their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. UBS Group dropped their price target on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Barclays dropped their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Finally, Truist Financial cut their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.